Copyright: ©Author(s) 2026.
World J Diabetes. May 15, 2026; 17(5): 114042
Published online May 15, 2026. doi: 10.4239/wjd.v17.i5.114042
Published online May 15, 2026. doi: 10.4239/wjd.v17.i5.114042
Table 1 Ultrasound grading of lipohypertrophy lesions and suggested clinical considerations
| Grade | Ultrasound imaging characteristics | Suggested clinical considerations |
| Grade 0 | Normal (no nodules or diffuse areas) | Continue routine site rotation education and periodic site checks |
| Grade 1 | Diffuse hyperechogenic areas without clear nodules | Avoid repeated injections into the same area; reinforce rotation and needle single-use; consider ultrasound mapping if glycemia remains unstable |
| Grade 2 | Nodules 1-5.9 mm (width at widest point) | Avoid injecting into lesion; monitor closely when switching to unaffected tissue because absorption may increase; reinforce education and rotation |
| Grade 3 | Nodules 6-9.9 mm | As Grade 2, with heightened vigilance and closer monitoring during site change in patients with prior hypoglycemia/Large dose requirements |
| Grade 4 | Nodules ≥ 10 mm | Strictly avoid injections into lesion; lesions may persist longer and require sustained site avoidance and monitoring; consider follow-up ultrasound in selected patients |
- Citation: Nguyen NTY, Tran HP, Luong TV, Nguyen DX, Tran DH, Hoai PHT, Lee MC, Dang HNN. From lipodystrophy to subcutaneous insulin depots: Overlooked mechanisms of glycemic variability in patients with diabetes. World J Diabetes 2026; 17(5): 114042
- URL: https://www.wjgnet.com/1948-9358/full/v17/i5/114042.htm
- DOI: https://dx.doi.org/10.4239/wjd.v17.i5.114042